Kunming Longjin Pharmaceutical Co., Ltd. (SHE:002750)

SHE:002750 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	50.85	261.74	210.74	191.07	102.04	123.98
Trading Asset Securities	219.44	33.42	123.41	213.27	327.45	287.61
Cash & Short-Term Investments	270.29	295.16	334.15	404.35	429.49	411.59
Cash Growth	-20.11%	-11.67%	-17.36%	-5.85%	4.35%	1.95%
Accounts Receivable	6.92	12.8	12.52	19.78	36.99	44.91
Other Receivables	5.59	5.44	7.26	18.16	22.64	6.06
Receivables	12.51	18.24	19.78	37.94	59.63	50.97
Inventory	25.25	21.86	28.65	27.78	32.9	54.67
Other Current Assets	3.06	2.91	1.48	0.97	0.74	2.38
Total Current Assets	311.11	338.18	384.06	471.04	522.77	519.61
Property, Plant & Equipment	167.02	170.36	178.27	202.48	223.25	239.53
Long-Term Investments	-	-	0.42	7	18.8	20.7
Goodwill	-	-	2.64	-	1.9	2.05
Other Intangible Assets	50.47	33.34	35.69	28.95	30.9	32.22
Long-Term Deferred Tax Assets	0.41	0.43	1.62	3.18	7.87	7.3
Long-Term Deferred Charges	24.46	25.83	21.67	16.93	17.4	16.49
Other Long-Term Assets	1.69	6.25	7.27	17.63	4.39	3.85
Total Assets	555.15	574.4	631.63	747.21	827.28	841.76
Accounts Payable	7.02	11.43	9.29	10.1	11.82	15.28
Accrued Expenses	10.47	18.83	25.03	38.06	53.93	46.52
Short-Term Debt	-	1	-	-	-	-
Current Portion of Leases	0.75	0.75	0.18	0.17	0.16	-
Current Income Taxes Payable	0.38	-	0	1.17	1.88	0.04
Current Unearned Revenue	3.66	2.04	0.79	1.63	3.83	2.33
Other Current Liabilities	16.9	14.57	14.84	36.52	41.76	36.12
Total Current Liabilities	39.19	48.63	50.14	87.66	113.4	100.28
Long-Term Leases	1.81	1.95	0.8	0.98	1.15	-
Long-Term Unearned Revenue	28.23	28.94	39.49	41.5	34.43	36.66
Long-Term Deferred Tax Liabilities	0.73	0.66	0.07	-	-	0.11
Other Long-Term Liabilities	-	-	-	12.3	-	-
Total Liabilities	69.96	80.19	90.51	142.44	148.99	137.05
Common Stock	400.5	400.5	400.5	400.5	400.5	400.5
Additional Paid-In Capital	-	0.02	-	0.11	0.11	0.11
Retained Earnings	63.82	69.94	111.39	182.42	238.53	235.44
Total Common Equity	464.32	470.46	511.89	583.03	639.15	636.05
Minority Interest	20.87	23.75	29.24	21.74	39.15	68.65
Shareholders' Equity	485.19	494.21	541.13	604.77	678.29	704.71
Total Liabilities & Equity	555.15	574.4	631.63	747.21	827.28	841.76
Total Debt	2.57	3.71	0.98	1.15	1.32	-
Net Cash (Debt)	267.72	291.46	333.17	403.19	428.17	411.59
Net Cash Growth	-18.21%	-12.52%	-17.37%	-5.83%	4.03%	1.95%
Net Cash Per Share	0.67	0.73	0.83	1.01	1.07	1.03
Filing Date Shares Outstanding	400.5	400.5	400.5	400.5	400.5	400.5
Total Common Shares Outstanding	400.5	400.5	400.5	400.5	400.5	400.5
Working Capital	271.92	289.54	333.92	383.38	409.37	419.33
Book Value Per Share	1.16	1.17	1.28	1.46	1.60	1.59
Tangible Book Value	413.85	437.12	473.55	554.08	606.35	601.78
Tangible Book Value Per Share	1.03	1.09	1.18	1.38	1.51	1.50
Buildings	-	182.84	182.84	182.88	183.05	175.96
Machinery	-	242.48	239.98	236.81	234	220.94
Construction In Progress	-	-	-	-	5.74	21.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.